Industry Areas:
Educational Background:
Bachelor of Laws (Honours)
Bachelor of Science (Honours) (Microbiology and Biochemistry).
Professional Experience:
Gary started in the IP profession in 1990 as an Examiner of Patents with the Australian Patent Office (now IP Australia). In 1991, he moved to Sydney and took up a position with a then leading Sydney based IP firm. In 1994, Gary took up a position with Wrays.
Gary's practice extends across the following areas in biotechnology and pharmaceuticals:
- advise towards strategic IP development in start-up companies and SME's;
- drafting patent applications;
- prosecution of patent applications;
- opinion work, including freedom to operate opinions, opinions for regulatory approval of pharmaceuticals as well as general due diligence opinion; and
- contentious matters including oppositions and court actions (infringement and revocation actions) in Australia and New Zealand.
Some of leading cases that Gary has acted in are:
(1) Genetics Institute Inc v Kirin-Amgen Inc (1996) 34 IPR 513 (Acted for Kirin Amgen);
(2) Pfizer Overseas Pharmaceuticals v Eli Lilly and Co (2005) 225 ALR 416 (Acted for Eli Lilly and Co);
(3) Genentech, Inc v Ludwig Institute for Cancer Research and Human Genome Sciences, Inc [2006] APO 20 (5 June 2006) (Acted for Human Genome Sciences Inc); and
(4) Danisco A/S v Novozymes A/S (No 2) [2011] FCA 282 (29 March 2011) (Acted for Danisco A/S).
A more detailed list of cases can be provided on request
Professional Affiliations:
- Institute of Patent and Trade Mark Attorneys of Australia (Fellow).
- Intellectual Property Society of Australia & New Zealand (Member).
- Licensing Executives Society of Australia & New Zealand (Member).
- Federation Internationale des Conseils en Propriete Industrielle (Member).
- Australian Society of Microbiology (Member).
- Australian Society of Molecular Biology & Biochemistry (Member).
- AusBiotech (Corporate member).
Professional_Profile_Gary Cox.pdf 